Henry Schein, Inc. (HSIC)
NASDAQ: HSIC · Real-Time Price · USD
78.65
-0.29 (-0.37%)
Jan 22, 2026, 3:04 PM EST - Market open
Henry Schein Revenue
Henry Schein had revenue of $3.34B in the quarter ending September 27, 2025, with 5.20% growth. This brings the company's revenue in the last twelve months to $12.94B, up 3.51% year-over-year. In the year 2024, Henry Schein had annual revenue of $12.67B with 2.71% growth.
Revenue (ttm)
$12.94B
Revenue Growth
+3.51%
P/S Ratio
0.75
Revenue / Employee
$517,520
Employees
25,000
Market Cap
9.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 12.67B | 334.00M | 2.71% |
| Dec 30, 2023 | 12.34B | -308.00M | -2.44% |
| Dec 31, 2022 | 12.65B | 246.00M | 1.98% |
| Dec 25, 2021 | 12.40B | 2.28B | 22.55% |
| Dec 26, 2020 | 10.12B | 133.20M | 1.33% |
| Dec 28, 2019 | 9.99B | 568.20M | 6.03% |
| Dec 29, 2018 | 9.42B | 534.17M | 6.01% |
| Dec 30, 2017 | 8.88B | -2.69B | -23.23% |
| Dec 31, 2016 | 11.57B | 941.95M | 8.86% |
| Dec 26, 2015 | 10.63B | 258.33M | 2.49% |
| Dec 27, 2014 | 10.37B | 810.74M | 8.48% |
| Dec 28, 2013 | 9.56B | 620.68M | 6.94% |
| Dec 29, 2012 | 8.94B | 409.73M | 4.80% |
| Dec 31, 2011 | 8.53B | 1.00B | 13.33% |
| Dec 25, 2010 | 7.53B | 988.45M | 15.12% |
| Dec 26, 2009 | 6.54B | 157.92M | 2.48% |
| Dec 27, 2008 | 6.38B | 490.53M | 8.33% |
| Dec 29, 2007 | 5.89B | 853.95M | 16.96% |
| Dec 30, 2006 | 5.04B | 509.92M | 11.27% |
| Dec 31, 2005 | 4.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 387.09B |
| Cencora | 321.33B |
| Cardinal Health | 234.31B |
| Accendra Health | 10.77B |
| 111, Inc. | 1.91B |
| Quipt Home Medical | 245.36M |
| EDAP TMS | 74.85M |
| Cosmos Health | 59.79M |
HSIC News
- 8 hours ago - Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET - Business Wire
- 7 days ago - Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer - Business Wire
- 8 days ago - Henry Schein, Inc. (HSIC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - Henry Schein Names Frederick M. Lowery as Chief Executive Officer - Business Wire
- 24 days ago - Henry Schein to Participate in the J.P. Morgan Conference in January - Business Wire
- 4 weeks ago - Henry Schein Provides Update on CEO Search Process - Business Wire
- 5 weeks ago - Top 2 Health Care Stocks That May Keep You Up At Night In December - Benzinga
- 6 weeks ago - Henry Schein Can Make Your Portfolio Smile - Seeking Alpha